One Day Extracellular Vesicles (EVs)-based Diagnostics and Therapeutics Summit 2019 (San Diego, CA, United States - March 28, 2019)

News provided by

Feb 08, 2019, 17:30 ET

DUBLIN, Feb. 8, 2019 /PRNewswire/ --

The "Extracellular Vesicle-based Dx & Rx Summit" conference has been added to ResearchAndMarkets.com's offering.

Extracellular Vesicles (EVs)-based Diagnostics and Therapeutics Summit 2019 focuses on the emerging field of deploying Exosomes as diagnostics and the engineering of exosomes and extracellular vesicles as a delivery tool for therapeutics moieties.

The ability to engineer EVs and the ability of EVs to target specific sites offers the ability to tailor therapeutics with exquisite targeting ability and opens up a whole new class of therapeutics which are classified as biologicals and which do not have the side effects and toxicity associated with small molecule-based therapies.

This summit explores this topic and takes a deep dive into the technology platforms, diseases targeted and clinical results-to-date.

Agenda:

THURSDAY, 28 MARCH 2019

10:00 - Conference Chair

Conference Chaiperson Opening Remarks
Lucia Languino, Professor of Cancer Biology, Thomas Jefferson University, United States of America
Summit Session Title: Emerging Themes in EV-based Diagnostics and Therapeutics
Summit Chairpersons: Professor Lucia Languino and Professor Paul Robbins

10:30 - Extracellular Vesicles and Aging

Paul Robbins, Professor, Department of Biochemistry, Molecular Biology, and Biophysics, and the Institute on the Biology of Aging and Metabolism, University of Minnesota Medical School, United States of America

11:00 - Keynote Presentation

Diversity of Extracellular Vesicles to Understand their Diagnostic and Therapeutic Potential
Jan Ltvall, Professor, University of Gothenburg; Founding President of ISEV, Sweden

This presentation will discuss the diversity of extracellular vesicles, primarily from a clinical perspective. Specifically, the presentation will show the presence of extracellular vesicles in tissues, specifically healthy tissues as well as different types of tumors. Data showing the presence of multiple types of EVs in different types of tissues will be presented, as well as the opportunities of utilizing that knowledge for clinical use.

11:30 - Keynote Presentation

Exosome Signaling in Brain Development
Hollis Cline, Chair of Neuroscience and Hahn Professor of Neuroscience, The Scripps Research Institute, United States of America

12:00 - Networking Lunch in the Exhibit Hall and Poster Viewing

12:30 - Keynote Presentation

Plasma Extracellular Vesicles Sub-fractions For Diagnosis of Cardiovascular Disease
Dominique PV de Kleijn, Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands, Netherlands

13:00 - EV Isolation from Biofluids

Shannon Pendergrast, Chief Scientific Officer, Ymir Genomics
We will present several novel products and methods for the rapid and effective isolation of biofluid extracellular vesicles (EVs).

13:30 - Keynote Presentation

Exosome Engineering for Delivery of Cytosolic Proteins: Principles and Therapeutic Applications
Chulhee Choi, Professor and Chair, BioMedical Imaging Center, Korea Advanced Institute of Science and Technology (KAIST), President, Cellex Life Sciences, Korea South

14:00 - Induced Tissue Regeneration (iTR) Using Extracellular Vesicles

Dana Larocca, VP Discovery Research, AgeX Therapeutics, United States of America

14:30 - Adipose-derived Stem Cell Extracellular Vesicles can be Specifically Tuned for Soft Tissue Repair and Wound Healing

John Ludlow, Executive Director, Regenerative Medicine, Zen-Bio, Inc., United States of America
Our research program is designed to provide critical proof-of-concept data demonstrating manufacturing conditions and wound healing properties of stem cell-derived extracellular vesicles.

15:00 - The HSP-Accessorized Exosome: Presence in States of Danger, Disease, and Disruption

Michael Graner, Associate Professor, Dept of Neurosurgery, University of Colorado Anschutz School of Medicine, United States of America

15:30 - Human Liver Stem Cell-derived Nano-EVs - A Broad Platform Technology for Cancer and Regeneration

Daniel Gau, Head of Business Development, Unicyte AG, Germany

16:00 - Cell-to-Cell Propagation of Pathogenic Aberrant Dipeptide Repeat Proteins in C9orf72-Linked Amyotrophic Lateral Sclerosis

Davide Trotti, Professor, Scientific Director, Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, United States of America

16:30 - NanoView BiosciencesRoutine Single EV Protein Biomarker Analysis

Clayton Deighan, Regional Sales Director, NanoView Biosciences

17:00 - Extracellular Vesicles Go Nuclear

Aurelio Lorico, Professor of Pathology, Touro University Nevada, United States of America

17:30 - Industry Panel Discussion Focusing on Circulating Biomarkers & Liquid Biopsy

For more information about this conference visit https://www.researchandmarkets.com/research/dbz4tq/one_day?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets